BioTechnology
Novadip’s €10.4M Raise Pushes a Patient-Derived Bone Graft Toward Its Pivotal Test
For children with congenital pseudarthrosis of the tibia, repairing a broken bone can become years of repeat surgery rather than a single recovery. The rare disorder causes the tibia to fracture and fail to unite, leaving some patients with impaired mobility and, in severe cases, the prospect of amputation. Novadip Biosciences is trying to change […]
Pixelgen Raises $15.5M to Scale Molecular Cell Mapping
Pixelgen Technologies is trying to show researchers something conventional protein measurements often miss: where proteins sit on a cell, which proteins gather together and how those relationships change with disease or treatment. The Stockholm company has built a high-throughput platform for mapping molecular cell architecture at nanoscale resolution, giving scientists another way to understand how […]
Remepy Raises $36M to Advance Hybrid Drugs Into Phase III
Modern medicine can be remarkably precise about what happens inside the body, yet much of what shapes recovery happens outside the pill. Movement, cognition, behavior and daily routines can influence how patients manage chronic disease, but those interventions often sit in separate programs, appointments and apps. Remepy is building around a different idea: what if […]